UWCCC Molecular Tumor Board Registry
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/1/2019 |
| Start Date: | March 2016 |
| End Date: | March 2021 |
| Contact: | Cancer Connect |
| Email: | cancerconnect@uwcarbone.wisc.edu |
| Phone: | 800-622-8922 |
UWCCC Precision Medicine Molecular Tumor Board Registry
This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor
Board, and to track patient outcomes.
Board, and to track patient outcomes.
Inclusion Criteria:
- Clinically suspected or histologically confirmed solid or hematological malignancy
- Undergoing genetic testing of tumor
- Ability to understand written informed consent document
- Willingness to sign written informed consent document
Exclusion Criteria:
- Pediatric patients (age<18 years) will be excluded due to a lack of expertise on the
molecular tumor committee
We found this trial at
1
site
600 Highland Ave.
Madison, Wisconsin 53792
Madison, Wisconsin 53792
(608) 263-6400
Principal Investigator: Mark Burkard, PhD
Phone: 800-622-8922
University of Wisconsin Carbone Cancer Center UW Carbone Cancer Center holds the unique distinction of...
Click here to add this to my saved trials
